Estimating the Benefit of Transplant Over Dialysis in Candidates Over 55 Years

Key Points Older kidney transplant candidates experience a gain in life years from transplantation. More updated models using a contemporary cohort are needed to guide current clinical practice for older adults. The magnitude of gain in life years from transplant has diminished in recent years, likely driven by candidate characteristics and policy changes. Background Life Years from Transplant (LYFT) is a measure of the predicted difference between the expected lifespan with and without a kidney transplant. The metric was originally proposed in 1999; since then, demographics of the kidney transplant candidate population have materially changed. Methods Using contemporary Scientific Registry of Transplant Recipients data, we propose more sophisticated methods for estimating LYFT with a focus on older kidney transplant candidates, a growing sector of the current candidate pool. We examine trends in predicted LYFT from 1995 to 2020. Results We show that among older patients on the deceased donor waitlist, transplant remains a better option compared with dialysis (overall LYFT=5 years). LYFT trends have diminished modestly (by <1 life year) over time, in part related to efforts to enhance access to transplantation through intercurrent policy changes. Conclusions Updated LYFT estimates remain informative clinical measures that can support patient-centered decision-making. However, less homogenous metrics with meaningful disaggregation are needed to inform institutional evaluation and policy change. Models should be repeatedly evaluated as demographics of the candidate pool evolve.

Authors

Institutions

Publication Details

Journal
Kidney360
Published
2025-01-22
DOI
https://doi.org/10.34067/kid.0000000710
Citations
1
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
1.99

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimating the Benefit of Transplant Over Dialysis in Candidates Over 55 Years

Margaret Stedman, Glenn M. Chertow, Jane C. Tan, Patrick Ahearn et al.
1 citations
Kidney360
Renal Transplantation Outcomes and Treatments
1.99
article

Estimating the Benefit of Transplant Over Dialysis in Candidates Over 55 Years

Margaret Stedman, Glenn M. Chertow, Jane C. Tan, Patrick Ahearn, Christine K. Liu
article en
1 citations

Abstract

Key Points Older kidney transplant candidates experience a gain in life years from transplantation. More updated models using a contemporary cohort are needed to guide current clinical practice for older adults. The magnitude of gain in life years from transplant has diminished in recent years, likely driven by candidate characteristics and policy changes. Background Life Years from Transplant (LYFT) is a measure of the predicted difference between the expected lifespan with and without a kidney transplant. The metric was originally proposed in 1999; since then, demographics of the kidney transplant candidate population have materially changed. Methods Using contemporary Scientific Registry of Transplant Recipients data, we propose more sophisticated methods for estimating LYFT with a focus on older kidney transplant candidates, a growing sector of the current candidate pool. We examine trends in predicted LYFT from 1995 to 2020. Results We show that among older patients on the deceased donor waitlist, transplant remains a better option compared with dialysis (overall LYFT=5 years). LYFT trends have diminished modestly (by <1 life year) over time, in part related to efforts to enhance access to transplantation through intercurrent policy changes. Conclusions Updated LYFT estimates remain informative clinical measures that can support patient-centered decision-making. However, less homogenous metrics with meaningful disaggregation are needed to inform institutional evaluation and policy change. Models should be repeatedly evaluated as demographics of the candidate pool evolve.

Kidney360Vol. 6(7)
VA Palo Alto Health Care System (US), Stanford University (US)
National Institute of Diabetes and Digestive and Kidney Diseases
Peace, Justice and strong institutions
Openalex Percentile: Top 20%
Renal Transplantation Outcomes and Treatments
1.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.